MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
6.91
+0.05
+0.73%
After Hours: 6.89 -0.02 -0.29% 19:59 12/05 EST
OPEN
6.85
PREV CLOSE
6.86
HIGH
6.91
LOW
6.77
VOLUME
3.72M
TURNOVER
--
52 WEEK HIGH
11.55
52 WEEK LOW
5.01
MARKET CAP
1.12B
P/E (TTM)
3.842
1D
5D
1M
3M
1Y
5Y
1D
Novavax (NVAX): Revisiting Valuation After Prolonged Share Price Weakness and Mixed Fair Value Signals
Simply Wall St · 1d ago
Is Novavax Now a Bargain After a 94.1% Five Year Share Price Slump?
Simply Wall St · 3d ago
Former FDA commissioners castigate plan to change vaccine approval standards
Seeking Alpha · 3d ago
Vaccine panel head who opposed COVID restrictions elevated to senior HHS role
Seeking Alpha · 4d ago
Bank of America Securities Sticks to Their Sell Rating for Novavax (NVAX)
TipRanks · 5d ago
Vaccine committee considers changes to childhood schedule, NY Times reports
TipRanks · 5d ago
Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million
Reuters · 5d ago
Novavax Inc. Stock Slips 5.1%, Underperforms Peers
Dow Jones · 5d ago
More
About NVAX
Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its recombinant protein-based nanoparticle technology has been shown to be highly immunogenetic. Its technology platform is used in its authorized COVID-19 vaccine and the R21/Matrix-M adjuvant malaria vaccine. Its late-stage programs include a COVID-19-Influenzavaccine candidate, and an influenza vaccine candidate. R21/Matrix-M adjuvant malaria vaccine, a malaria vaccine developed by its partner. It provides Matrix-M adjuvant for use in various programs in preclinical and clinical stage, and preclinical investigations.

Webull offers Novavax Inc stock information, including NASDAQ: NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.